Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79146.081.485%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Tyra Biosciences Inc

TYRANASDAQ
Trade with Public
Trade with Public
$28.65
3.7915.25%
At close: Sep 4, 5:00 PM EST
$28.65
N/A
After Hours: Sep 4, 4:36 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Tyra Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tyra Biosciences (TYRA).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

1S.Buy
12Buy
Consensus RatingBuy# Analysts13Avg. Consensus PT$45Upside to Avg. PT+58.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 4, 2026HC Wainwright & Co.Mitchell S. KapoorMaintainedBuy$45
Jun 17, 2026Jones TradingMatthew MurrayInitiateBuy$56
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $45 price target.
Benzinga Newsdesk

TD Synnex To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Friday

Analysts change outlook on top Wall Street names. SNX, ORCL, EDU, ENS, SHOO, RH, have price target changes and ratings upgrades/downgrades.
Avi Kapoor

Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed outlook on top names. See full list of rating changes on analyst ratings page: CHEF, NAVN, INTC, HOOD, GPCR, OTLK, ORCL.
Avi Kapoor

Micron Technology To $900? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst ratings page for complete view.
Avi Kapoor

PRO
B of A Securities Maintains Buy on Tyra Biosciences, Raises Price Target to $42

B of A Securities analyst Geoff Meacham maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $37 to $42.
Benzinga Newsdesk

This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Wall Street analysts changed ratings on top names. Check our analyst ratings page for full updates. THG, BFRI covered.
Avi Kapoor

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved